Background In 2009, mandatory folic acid fortification of bread-making flour was introduced in Australia to reduce the birth prevalence of preventable neural tube defects (NTDs) such as spina bifida. Before the introduction of the policy, modelling predicted a reduction of 14-49 NTDs each year. Objective Using real-world data, this study provides the first ex-post evaluation of the cost effectiveness of mandatory folic acid fortification of bread-making flour in Australia. Methods We developed a decision tree model to compare different fortification strategies and used registry data to quantify the change in NTD rates due to the policy. We adopted a societal perspective that included costs to industry and government as well as healthcare and broader societal costs. Results We found 32 fewer NTDs per year in the post-mandatory folic acid fortification period. Mandatory folic acid fortification improved health outcomes and was highly cost effective because of the low intervention cost. The policy demonstrated improved equity in outcomes, particularly in birth prevalence of NTDs in births from teenage and indigenous mothers. Conclusions This study calculated the value of mandatory folic acid fortification using real-world registry data and demonstrated that the attained benefit was comparable to the modelled expected benefits. Mandatory folic acid fortification (in addition to policies including advice on supplementation and education) improved equity in certain populations and was effective and highly cost effective for the Australian population.
Mandatory folic acid fortification (in addition to policies including advice on supplementation and education) improved equity and was effective and almost cost neutral for the Australian population assuming a health services perspective. Including productivity gain resulted in a net benefit for society.
The introduction of the mandatory folic acid fortification initiative may improve social welfare by reducing the health impact associated with NTDs as well as the medical and community costs of caring for those with NTDs. Previous economic evaluations have evaluated the expected cost effectiveness of mandatory fortification [2] [3] [4] [5] [10] [11] [12] [13] [14] [15] [16] [17] , with few ex-post analyses [10, 12, [15] [16] [17] . Pre-fortification economic evaluations relied on predictive modelling of the changes in NTD rates after folic acid fortification in Australia [2] [3] [4] [5] . These papers were limited by the assumptions made about the effectiveness and costs of the programme. This study used NTD registry data to assess the impact of mandatory folic acid fortification in Australia. This is the first ex-post study in Australia using collected data on NTD rates (isolated rates by maternal age group) using a societal perspective.
Methods

Analytic Framework
This study used a cost-utility analysis approach to assess the cost and benefits of mandatory fortification (as introduced in 2009) versus the pre-mandatory fortification period (practice before 2009). The practice before 2009 included voluntary fortification, with a mixture of policies such as education programmes and supplementation. These practices continued into the post-fortification periods. A societal perspective that included carer and productivity costs was adopted for the analysis, and all costs and benefits are reported in year 2014 values. The year 2014 was chosen as the base year, as this was the year dietary intake information [18] and cost data from Catalyst for costs of fortification from millers and bakers [19] were available.
We developed a decision tree model using TreeAge ® Pro software (Massachusetts, USA; 2015 version). Because the intervention potentially affected subgroups of the population in different ways, the decision tree ( Fig. 1 ) included separate branches for women of childbearing age (16-44 years) and the rest of the population, subdivided by sex and age based on Australian Bureau of Statistics (ABS) data from 2014 [20, 21] . The results from the model represent the average costs and benefits for an individual and were multiplied by the size of the Australian population to determine costs and benefits on a national level.
Five age groups were used for pregnant women of childbearing age: < 20 years, 20-24 years, 25-29 years, 30-34 years and ≥ 35 years. For each age group, the pregnancy was defined as either NTD affected or not. NTDaffected pregnancies were categorised as anencephaly, encephalocele or spina bifida and resulted in termination or proceeded to birth. NTD-affected births were either
Introduction
In 2009, mandatory folic acid fortification of wheat flour for bread making was introduced in Australia to reduce the birth prevalence of neural tube defects (NTDs) [1] . Modelling studies conducted before the policy was introduced estimated a reduction of 14-49 NTDs each year [1] and that the policy would be cost effective [2] [3] [4] [5] . However, these conclusions relied on baseline NTD rates and predictive modelling of the subsequent change in NTD rates following fortification.
NTDs are birth defects of the spine, spinal cord and brain and cause excessive morbidity and premature mortality. NTDs have a spectrum of clinical manifestations, including anencephaly, encephalocele and spina bifida (myelomeningocele), depending on the level and extent of the neural tube closure [1] . NTDs are potentially diagnosed before 20 weeks' gestation during contemporary antenatal care. A proportion of those diagnosed terminate the pregnancy, and some NTDs, such as anencephaly, are incompatible with survival after birth. Defects are corrected surgically if possible. Some NTDs are preventable with sufficient folate intake by women before conception and during pregnancy [6] .
In Australia, state/territory-based registries collect birth prevalence data on NTD-affected births, including anencephaly, encephalocele and spina bifida. The birth prevalence rate of NTDs has decreased in Australia since the 1990s [6] . The annual decline in the rate of NTDs between 1998 and 2008 averaged 0.2 per 10,000 births and was most evident for spina bifida, with no appreciable change in the birth prevalence of either anencephaly or encephalocele [6] . This decrease was attributed to a suite of policies, including education, voluntary fortification of bread-making flour and guidance on natural and voluntary supplementation. However, significant inequities, including the higher rates of NTDs in children born to teenage mothers and Aboriginal and Torres Strait Islander mothers, and the possibility of further reducing the birth prevalence of NTDs led to the mandatory fortification initiative [7] .
Since mandatory folic acid fortification, levels of folic acid in the food supply have increased, as have the nutrient intakes and the nutrient status of the population [8] . Mandatory folic acid fortification in Australia has resulted in an increase of folic acid in bread from 20-29 to 134-200 µg/L and an increased intake in women of childbearing age from 102 to 247 µg/day from 2009 to 2014 [9] . The rate of NTDs statistically significantly (14.4%) decreased (from 10.2 to 8.7 per 10,000 conceptions that resulted in a birth), and this decrease was greater in the Aboriginal and Torres Strait Islander population (75%) and in babies of teenage mothers (55%) [9] . stillbirths or live births, where the infant could either survive the 28-day neonatal period or die.
Timing of Costs and Benefits
The fortification programme affects healthcare costs and outcomes over a population's lifetime, so we used life expectancy (78 years) as the time horizon in the study [22] . Future costs and benefits were discounted using the annual discount rate of 5% (base case) [23] . Table 1 summarizes the parameters used in the model.
Epidemiology Data
Women of childbearing age (16-44 years) accounted for 20% of the Australian population. A total of 6% were pregnant, and the distribution of maternal age was based on ABS data from 2014 [20] .
Birth Prevalence of Neural Tube Defects (NTDs)
The birth prevalence of NTDs was based on the rate of NTD per 10,000 conceptions that resulted in birth 1 by maternal age. Data were available from New South Wales (NSW), Queensland, Western Australia, South Australia and the Northern Territory, which is five of the eight states and territories of Australia and represents 72% of the Australian population.
2 Data were divided into the following timeframes (for conception): Pre-mandatory fortification period NTD types modelled were anencephaly, encephalocele and spina bifida. NTDs were categorised into isolated NTDs and non-isolated NTDs [6] . NTD rates for the 'control' arm of the model (pre-fortification) were based on conceptions occurring in the baseline period. NTD rates for the 'intervention' arm of the model (post-fortification) were based on conceptions occurring in the standard period. These rates were converted to probabilities. The odds ratio was applied to calculate the probability of an event after folic acid mandatory fortification in each maternal age group. The rate of NTDs reported in the largest state in Australia, NSW, was consistently lower than that reported in other states because of reporting differences [6] . In scenario analyses, NSW NTD rates were excluded to account for the under-reporting.
The registry data revealed a linear downward trend in the overall prevalence of NTDs between 1998 and 2008, with an average annual fall of 0.23 NTDs per 10,000 births [24] . The model accounted for this downward trend in a scenario analysis to capture the benefit associated with the mandatory fortification programme assuming the downward trend continued. We adjusted the 0.23 reduction in NTD rate for time by using the midpoint of the data collection period (December 2007 for baseline and June 2010 for standard period) and converting it to an annual rate by multiplying by the difference between the two timepoints (2.6 years). This rate was applied to the pre-mandatory fortification arm (assuming the fall would be the same across all maternal age groups). 1 The NTD birth prevalence is the number of NTD-affected individuals among all births (live births and stillbirths) divided by the number of total babies born (live births and stillbirths) in a specified time and place. Births include termination of pregnancy after 20 weeks' gestation. NTD rate is the number of NTD-affected babies from a birth or termination of pregnancy for congenital anomaly regardless of pregnancy gestation divided by the number of total babies born (live births and stillbirths) in a specified time and place. 2 The NTD rate collection was incomplete in NSW. For the probabilistic sensitivity, analysis beta distributions were applied to probabilities and utility values and the gamma distribution was used for costs CI confidence interval, NND neonatal death, NTD neural tube defect, NSW New South Wales, $A Australian dollar a Lower and upper estimates for probabilities and utilities correspond to 95% CI and for costs, the mean was halved and doubled b Costs of fortification include industry and government costs estimated at the per capita level 
Outcome Measures
The primary outcome measured was the incremental number of quality-adjusted life-years (QALYs) gained due to the mandatory fortification intervention compared with the alternative. Secondary outcomes included the incremental number of life-years gained and NTD cases avoided. Both termination of pregnancy (TOP) and stillbirth resulted in the life expectancy of a non-NTD-affected birth discounted by 2 years to reflect no change in family size. For neonates with encephalocele or spina bifida who were alive at birth but died by 28 days (known as neonatal death [NND]), we used the 1-, 7-and 28-day survival probability estimates from a US population [25] to estimate the average survival of NND, resulting in 0.04 life-years for encephalocele and 0.02 life-years for spina bifida.
For neonatal survivors (NNS), the life expectancies of patients with encephalocele and spina bifida were calculated using the 20-year survival probabilities of 0.673 [26] and 0.852 [27] , respectively. The probability of survival was calculated along with the relative risk of death for the NTD types compared with the survival of the general population split by sex. The estimated life expectancies for encephalocele and spina bifida were re-weighted to the sex ratio of Australian births in 2014, resulting in 76.80 and 77.70 years, respectively [21, 22] .
Utility measures for spina bifida were based on US data from 2005 using the Health Utility Index 2 (HUI-2) [28] . This study reported utility results by lesion location (sacral, lower lumbar and thoracic). In the model, it was assumed that patients with encephalocele would have the same utility as patients with spina bifida with a thoracic lesion. A review of the literature found some literature on the utility values for TOP [29] [30] [31] . A scenario analysis included a utility decrement for TOP (0.087) from a time trade-off study of 534 women [30] . The 0.087 decrement was calculated as normal birth (0.923) minus elective abortion on future unaffected birth (0.836).
Costs
Costs for NTDs were reported in Australian dollars ($A), year 2014 values, and converted using purchasing power parities when applicable. Estimations of the healthcare resources and sources are presented in the Appendix, in the Electronic Supplementary Material (ESM). The healthcare costs of NTDs included the initial hospitalisation based on Australian Refined Diagnosis-Related Groups (AR-DRG) procedure codes of patients admitted to public hospitals, including non-NTD pregnancy, TOP, stillbirth, anencephaly, encephalocele and spina bifida [32] . Healthcare resource use from a US study in patients with spina bifida was higher than in age-matched counterparts for inpatient admissions and outpatient visits but not for prescription drugs [33] . Australian unit costs for acute admitted care from National Hospital Cost Data Collection [34] and for general practitioner and specialist visits using the Medicare Benefits Schedule [35] were multiplied by frequencies per year from the US study [33] . No costing studies were identified for patients with encephalocele. The model assumed a 1.2 multiplication factor compared with the cost of treating spina bifida, given the lower survival rates (Haywood, P, personal communication). Yearly assistive technology costs were applied from ages 1 to 65 years in patients with spina bifida and those with encephalocele based on the average annual Medicaid cost by 848 enrolees in 2010 [36] . The mandatory fortification programme costs for industry were split into total start-up ($A2,893,500) and ongoing ($A456,600) costs [7, 19] . The ongoing per capita costs from industry and the government costs were calculated by dividing by the estimated resident population in 2014, equating $A0.019 and $A0.006, respectively. The start-up government costs were projected costs of enforcement from the 2007 First Review Report of the P295 Proposal inflated to $A, year 2014 values, totalling $A33,067 [7] . A scenario analysis tested the inclusion of start-up implementation costs.
Societal costs included the costs of lost carer time from employment and the productivity losses of people with NTDs [23] . The estimate of carer hours worked per week was based on a US study of parents of children with spina bifida (n = 98) by lesion location (indicator of care need), e.g. parents of children with a sacral lesion worked fewer hours than parents of children with a thoracic lesion [28] . The proportion of patients with spina bifida by lesion location (thoracic, lumbar and sacral) was estimated using Australian hospital data [37] . The Australian proportion by lesion was multiplied by the hours of work lost per lesion location as reported in the US study. For carer's lost productivity, the human capital approach [38] was used, multiplying hours lost from work with an average hourly wage of $A35.3 (year 2014 values). Productivity loss for people with NTDs was estimated as the proportion of individuals employed with a disability (physical restriction as a proxy for spina bifida) and the reduced hours worked compared with a person without a disability, using ABS employment statistics [39] .
Sensitivity Analysis
Univariate sensitivity analyses were conducted on the model parameters using 95% confidence intervals (CIs). Formulas used to estimate the parameters are presented in the appendix in the ESM. For the proportion of NTD rates, the lower and upper estimates were calculated from the relative risks, converted to odds ratios and then converted to 95% CIs of annual rates. For probabilities with a beta distribution, the 95% CIs were calculated using the standard errors. The 95% CIs for survival probabilities and utility values were as reported in the literature. Cost estimates were halved and doubled for the lower and upper estimates, respectively. We conducted a probabilistic sensitivity analysis (PSA) wherein distributions were assigned to the relevant parameters used in the univariate sensitivity analysis. Beta distributions were applied to probabilities and utility values, and the gamma distribution was used for costs. Monte Carlo simulation with 10,000 draws was performed. Scenario analyses included (1) adjustment of the background rate of decrease in NTDs from 1998 to 2008; (2) excluding the NSW data; (3) utility decrements experienced by mothers for TOP and stillbirth pregnancy outcomes; (4) costs of start-up (implementation costs) included in the post-mandatory fortification alternative to represent the situation in 2009 when the initiative was introduced; (5) cost of start-up (implementation costs) included in pre-mandatory fortification with no ongoing fortification costs in the post-mandatory period to represent a scenario of returning to voluntary fortification; (6) removing discounting; and (7) removing the multiplication factor for encephalocele.
Results
The modelled results are presented in Table 2 . In the base case, 233 NTDs per year occurred without mandatory folic acid fortification compared with 201 NTDs with mandatory fortification. Therefore, approximately 32 fewer NTD-affected pregnancies occurred in 2014 because of mandatory folic acid fortification. Extrapolating the model over the lifetime of the cohort, it was estimated that an additional 301 life-years and 293 QALYs were gained across the Australian population per year with mandatory fortification.
Compared with voluntary fortification, the mandatory fortification intervention was estimated to be highly cost effective. The annual ongoing costs for folic acid fortification from industry ($A456,600) and government ($A147,677) was estimated at $A0.026 per capita per year. The incremental cost reduction was $A1,450,326 with mandatory folic acid fortification compared with no mandatory fortification, including productivity changes. Therefore, mandatory fortification was the dominant strategy (health producing and cost saving) compared with no mandatory fortification and the other prevention strategies. When only including health costs, the incremental costeffectiveness ratio (ICER) was $A373 per QALY gained, indicating the programme was highly cost effective. Figure 2 is a tornado diagram illustrating the results of varying the model parameters. The model was most sensitive to the estimation of the post-fortification rate of NTDs by age group. 
One-Way Sensitivity Analysis
Probabilistic Sensitivity Analysis
The PSA was performed with 10,000 iterations. At a willingness-to-pay threshold of $A50,000 per QALY gained, mandatory folic acid fortification had a 100% probability of being cost effective when compared with no mandatory fortification (Fig. 3 ).
Scenario Analysis
All scenarios resulted in fewer NTDs with mandatory folic acid fortification ( Table 2 ). The inclusion of the background rate reduced the effectiveness of mandatory folic acid fortification from 293 QALYs to 131 QALYs gained; and from 32 NTDs to 14 NTDs. Similarly, the exclusion of the NSW data increased the number of NTDs avoided to 40 and increased the modelled benefit to 365 QALYs. This was because, without the lower NSW NTD rate, the estimated rate of NTDs increased and the potential benefit of mandatory fortification also increased. The majority of the costs for mandatory fortification were incurred at the time of implementation because of changes in processing and packaging. In the first year of moving to mandatory folic acid fortification, the start-up costs to the government and industry were substantial enough to reverse the discounted savings. Conversely, the change back from mandatory fortification to the pre-mandatory fortification suite of policies would cost approximately $A4.5 million in the first year (year 2014 values). Removing discounting (discount rate 0%) increased the QALYs gained to 1111 and consequently reduced the ICER as the QALY increase was more than the cost reduction. Assuming the cost of the healthcare treatment for encephalocele was the same as that for spina bifida increased the cost of mandatory fortification.
Discussion
Before mandatory folic acid fortification of bread-making flour in Australia in 2009, the suite of policies included voluntary fortification and advice on folic acid supplementation for pregnant women and those planning pregnancies. Mandatory folic acid fortification increased the folic acid intake of women who do not take folic acid supplements before pregnancy [18] . This is especially important for unplanned pregnancies.
The introduction of mandatory folic acid fortification led to fewer NTDs and was cost neutral compared with the alternative of no mandatory folic acid fortification. Each year of mandatory fortification resulted in $A1,500,000 (year 2014 values) in health system savings and increased productivity. Mandatory fortification also improved equity, with a larger reduction in the NTD rate in high-risk subgroups, such as babies of teenage mothers and Aboriginal and Torres Strait Islander mothers. Given the NTD rate was highest in these subgroups before the introduction of the mandatory policy, the change was most pronounced in the babies of Aboriginal, Torres Strait Islander and teenage mothers. The statistically significant decrease was higher in the Aboriginal and Torres Strait Islander mothers (75%; from 19.6 to 5.1 per 10,000 conceptions that resulted in a birth) and teenage mothers (55%; from 14.9 to 6.7 per 10,000 conceptions that resulted in a birth) than in the total population [9] .
The modelled reduction in NTDs was approximately 32 per year in the base case. In a scenario analysis, after adjusting for the declining background rate of NTDs, it was approximately 14 per year. This was consistent with the modelled estimates before the introduction of mandatory fortification, which were a reduction of 14-49 NTDs in 300-350 pregnancies in Australia affected by an NTD each year [7] . This analysis demonstrated that the benefits attained from the policy were comparable to the predicted benefits, albeit at the lower end of the estimates. Dalziel et al. [3] estimated the mandatory fortification (200 μg/100 g flour) would result in 18.4 NTDs prevented per year in Australia. Similarly, Rabovskaja et al. [2] estimated that mandatory fortification would result in 31 NTD cases prevented per year in Australia, which is in line with the observed annual reduction. Differences in the modelling assumptions between the Australian studies and this study include the use of disability-adjusted life-years (DALYs) in Dalziel et al. [3] , whereas this study relied on quality-of-life estimates. Overall, the utility value used for spina bifida was similar between the three studies; however, TOP was assigned no disutility in the current study, was considered a minor disability in Dalziel et al. [3] , and was assigned 0.01 DALYs and 0 utility for Rabovskaja et al. [2] . Another difference was that both Dalziel et al. [3] and Rabovskaja et al. [2] included a loss of consumer choice from mandatory fortification ($A1-3.19).
Establishing attribution in a public health initiative such as this is challenging, since it is possible that changes in the NTD-affected pregnancy rate before and after mandatory folic acid fortification were not solely due to the initiative. Our model addressed this issue of attribution in a scenario analysis by adjusting for the declining annual background NTD rate due to pre-existing policies. The scenario analyses (exclusion of NSW data and inclusion of background rate) demonstrated that the approach taken in this evaluation was conservative. No information on changes in folic acid supplementation or education was available. It is possible that folic acid supplementation may have increased, given the additional publicity during the introduction of mandatory folic acid fortification.
Mandatory fortification was implemented in 2009, and data on NTD rates were reported up to 2011, the duration of which was a limitation of the economic evaluation. NTD data were from five of the eight states and territories, making up over 70% of the total births in Australia. Our analysis assumed these rates were applicable to the entire Australian population. Given NTDs are relatively rare, the annual rates do vary. The inclusion of the NSW dataset is conservative given the NSW NTD rates are artificially low because of incomplete data collection [6] . It is advised that monitoring continues and that the economic evaluation be repeated in the future with more complete data [8] . The survival estimates were taken from Shin et al. [27] , who utilised data from 1983 to 2003, so it is likely the survival of patients with spina bifida has increased over time. Shin et al. [27] demonstrated that survival from birth to age 5 years increased from 88.3% for the 1990-1996 birth cohort to 90.7% for the 1997-2003 cohort.
Several hypothesised risks are associated with excessive folic acid intake. A series of case reports chronicled the rapid progression of neurological dysfunction in patients treated with large doses of folic acid in the 1940s (approximately 5 mg). Previous economic evaluations have incorporated the unintended consequence of high folic acid levels masking vitamin B 12 deficiency, leading to the exacerbation of neurological complications and cognitive decline [2] . If this is a problem in contemporary medicine, it is likely to be restricted to the elderly or those with particularly poor diets. There is no robust evidence to suggest this is a problem with levels of folic acid fortification without folic acid supplementation [1, 40] . Rabovskaja et al.
[2] included adverse events (severe neuropathy cases) in the base case, using the proportion of people with levels of folic acid > 1 mg.
The model excluded start-up implementation costs of mandatory fortification for the government and industry so that only ongoing costs were included. Inclusion of the start-up costs (representing the situation in 2009) increased the cost of 'post-mandatory' fortification to be the costlier alternative. However, since the introduction of the policy, it is now less costly than the alternative of changing back to the mix of policies without mandatory fortification (return to voluntary fortification).
Mandatory folic acid fortification of bread-making flour could restrict consumer choice [41] . However, organic and unleavened bread are not required to be fortified with folic acid [8] . In a survey from Western Australia, the majority of respondents stated they would neither avoid nor seek out folic acid-fortified bread [42] . Therefore, the potential costs (or loss of consumer surplus due to restricted choice) of seeking non-fortified bread has not been included. This study included productivity costs, which is commonly recommended in pharmacoeconomic guidelines [38] , although the exact method differs. Australian guidelines recommend that the base case exclude productivity gains and that these be included in a supplementary analysis [23] . Both results have been presented in this analysis.
Most of the previous studies have been ex ante evaluations; this is the first ex post evaluation in Australia. This is the first Australian study to calculate the value of mandatory folic acid fortification using real-world registry data. It used a scenario analysis to account for the background trend in NTD rates. This study proves that, even under conservative assumptions, it is extremely likely that mandatory fortification has improved health and reduced healthcare costs for the Australian population.
Conclusions
The ex-post evaluation of mandatory folic acid fortification (in addition to existing policies, including advice on supplementation and education) found the intervention was effective and highly cost effective for the Australian population. Reductions in NTDs were consistent with the modelled estimates conducted before the policy was introduced, demonstrating the value of using registry data for these evaluations. However, longer-term data collection on NTD rates is required to confirm these findings in the future. The implementation of mandatory folic acid fortification has contributed to reductions in inequities of distribution of NTDs amongst population groups, including teenage, Aboriginal and Torres Strait Islander mothers.
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